MannKind (MNKD) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

MannKind Revenue Highlights


Latest Revenue (Y)

$285.50M

Latest Revenue (Q)

$19.73M

Main Segment (Y)

Royalty

MannKind Revenue by Period


MannKind Revenue by Year

DateRevenueChange
2024-12-31$285.50M43.50%
2023-12-31$198.96M99.42%
2022-12-31$99.77M32.25%
2021-12-31$75.44M15.81%
2020-12-31$65.14M3.34%
2019-12-31$63.04M126.28%
2018-12-31$27.86M137.20%
2017-12-31$11.74M-93.28%
2016-12-31$174.76M100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31--100.00%
2012-12-31$35.00K-30.00%
2011-12-31$50.00K-46.24%
2010-12-31$93.00K100.00%
2009-12-31--100.00%
2008-12-31$20.00K100.00%
2007-12-31$10.00K-90.00%
2006-12-31$100.00K100.00%
2005-12-31-100.00%
2004-12-31-100.00%
2003-12-31-100.00%
2002-12-31--100.00%
2001-12-31$326.00K111.69%
2000-12-31$154.00K-

MannKind generated $285.50M in revenue during NA 2024, up 43.50% compared to the previous quarter, and up 452.91% compared to the same period a year ago.

MannKind Revenue by Quarter

DateRevenueChange
2024-09-30$19.73M-72.75%
2024-06-30$72.39M9.24%
2024-03-31$66.26M13.32%
2023-12-31$58.47M14.09%
2023-09-30$51.25M5.43%
2023-06-30$48.61M19.65%
2023-03-31$40.63M12.67%
2022-12-31$36.06M9.85%
2022-09-30$32.83M73.73%
2022-06-30$18.89M57.56%
2022-03-31$11.99M-4.18%
2021-12-31$12.52M-43.65%
2021-09-30$22.21M-4.59%
2021-06-30$23.28M33.52%
2021-03-31$17.44M-5.46%
2020-12-31$18.44M20.13%
2020-09-30$15.35M1.57%
2020-06-30$15.11M-6.90%
2020-03-31$16.23M1.51%
2019-12-31$15.99M9.58%
2019-09-30$14.60M-2.71%
2019-06-30$15.00M-14.02%
2019-03-31$17.45M8.83%
2018-12-31$16.03M258.74%
2018-09-30$4.47M14.80%
2018-06-30$3.89M12.35%
2018-03-31$3.46M-23.51%
2017-12-31$4.53M121.73%
2017-09-30$2.04M-5.55%
2017-06-30$2.16M-28.12%
2017-03-31$3.01M-75.74%
2016-12-31$12.40M-92.36%
2016-09-30$162.35M100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31--100.00%
2012-09-30$35.00K100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30--100.00%
2011-03-31$50.00K100.00%
2010-12-31-100.00%
2010-09-30--100.00%
2010-06-30$93.00K100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-09-30-100.00%
2008-06-30--100.00%
2008-03-31$20.00K100.00%
2007-12-31--

MannKind generated $19.73M in revenue during Q3 2024, up -72.75% compared to the previous quarter, and up 40.58% compared to the same period a year ago.

MannKind Revenue Breakdown


MannKind Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
License and Service$100.84M$41.91M---
Product$82.33M$56.25M$39.17M$32.32M-
Royalty$102.33M$15.60M---
Service--$3.10M--
Product Sales--$81.07M--
License And Service---$22.02M$9.56M

MannKind's latest annual revenue breakdown by segment (product or service), as of Dec 24: Royalty (35.84%), License and Service (35.32%), and Product (28.84%).

Quarterly Revenue by Product

Product/ServiceDec 24Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19
Royalty$75.25M$27.08M$9.07M$6.22M$304.00K---------------
Product$62.60M$19.73M$17.44M$16.26M$12.72M$9.83M$11.34M$9.75M$10.06M$7.28M----------
License And Service-$23.27M$14.78M$10.68M$8.71M$7.14M$6.08M$5.51M$3.29M$2.63M$1.58M$1.98M$3.36M$2.39M------
License and Service---$22.64M$10.26M$9.01M--------------
Product Sales-------$26.47M$26.18M$17.42M----------
Service-------$513.00K$430.00K$1.17M----------

MannKind's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Royalty (54.59%), and Product (45.41%).

MannKind Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
UTHRUnited Therapeutics$2.88B$748.90M
BMRNBioMarin Pharmaceutical$2.85B$733.87B
TECHBio-Techne$1.16B$297.03M
KNSAKiniksa Pharmaceuticals$423.24M$112.21M
MNKDMannKind$285.50M$19.73M
LEGNLegend Biotech$285.14M$93.99M
ADAPAdaptimmune Therapeutics$178.03M$128.23M
DAWNDay One Biopharmaceuticals$131.16M$20.07M
SGMOSangamo Therapeutics$57.80M$356.00K
LQDALiquidia$14.00M$4.45M
VSTMVerastem$10.00M$10.00M
AFMDAffimed$8.28M$155.00K
IMMPImmutep$3.51M$2.11M
SABSSAB Biotherapeutics$2.24M$263.14K
INKTMiNK Therapeutics--
PCVXVaxcyte--
ELEVElevation Oncology--
LRMRLarimar Therapeutics--
KTTAPasithea Therapeutics--

MNKD Revenue FAQ


What is MannKind’s yearly revenue?

MannKind's yearly revenue for 2024 was $285.5M, representing an increase of 43.50% compared to 2023. The company's yearly revenue for 2023 was $198.96M, representing an increase of 99.42% compared to 2022. MNKD's yearly revenue for 2022 was $99.77M, representing an increase of 32.25% compared to 2021.

What is MannKind’s quarterly revenue?

MannKind's quarterly revenue for Q3 2024 was $19.73M, a -72.75% decrease from the previous quarter (Q2 2024), and a -61.51% decrease year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $72.39M, a 9.24% increase from the previous quarter (Q1 2024), and a 48.91% increase year-over-year (Q2 2023). MNKD's quarterly revenue for Q1 2024 was $66.26M, a 13.32% increase from the previous quarter (Q4 2023), and a 63.10% increase year-over-year (Q1 2023).

What is MannKind’s revenue growth rate?

MannKind's revenue growth rate for the last 3 years (2022-2024) was 186.16%, and for the last 5 years (2020-2024) was 338.27%.

What are MannKind’s revenue streams?

MannKind's revenue streams in c 24 are License and Service, Product, and Royalty. License and Service generated $100.84M in revenue, accounting 35.32% of the company's total revenue, up 140.62% year-over-year. Product generated $82.33M in revenue, accounting 28.84% of the company's total revenue, up 46.37% year-over-year. Royalty generated $102.34M in revenue, accounting 35.84% of the company's total revenue, up 556.04% year-over-year.

What is MannKind’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of MannKind was Royalty. This segment made a revenue of $102.34M, representing 35.84% of the company's total revenue.